Free Trial
OTCMKTS:PXSLY

Pharmaxis (PXSLY) Stock Price, News & Analysis

Pharmaxis logo
$0.88 0.00 (0.00%)
As of 06/8/2021

About Pharmaxis Stock (OTCMKTS:PXSLY)

Key Stats

Today's Range
$0.88
$0.88
50-Day Range
$0.88
$0.88
52-Week Range
$0.62
$1.47
Volume
N/A
Average Volume
1,000 shs
Market Capitalization
$26.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol business, and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of amine oxidase inhibitors comprising semicarbazide-sensitive amine oxidase for diabetic retinopathy; selective lysyl oxidase like inhibitors targeting chronic fibrotic diseases, such as NASH, pulmonary fibrosis, kidney fibrosis, and cardiac fibrosis; and pan-lysyl oxidase inhibitors targeting severe fibrotic indications, which includes cancers and scarring. It is also developing Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was founded in 1998 and is headquartered in Frenchs Forest, Australia.

Receive PXSLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharmaxis and its competitors with MarketBeat's FREE daily newsletter.

PXSLY Stock News Headlines

Recession Fears Mounting? 2 AI Stocks to Watch Now
2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines. But even in uncertain times, innovation doesn’t slow down. In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles. Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar.
Pharmaxis Ltd March Quarter Shareholder Update
See More Headlines

PXSLY Stock Analysis - Frequently Asked Questions

Pharmaxis' stock was trading at $0.88 at the start of the year. Since then, PXSLY stock has increased by 0.0% and is now trading at $0.88.
View the best growth stocks for 2025 here
.

Shares of PXSLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:PXSLY
Fax
N/A
Employees
69
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.75 million
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
22.00

Miscellaneous

Free Float
N/A
Market Cap
$26.53 million
Optionable
Not Optionable
Beta
1.22

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (OTCMKTS:PXSLY) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners